COBOLIMAB

UNII:	3K5H4TX2KP
Formula:
Preferred Substance Name:	COBOLIMAB

2022215-65-0
COBOLIMAB [INN]
COBOLIMAB [USAN]
COBOLIMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HEPATITIS A VIRUS CELLULAR RECEPTOR 2 (HAVCR2)) (HUMANIZED CLONE ABT2 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONE ABT2 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HUMANIZED (1-440) (VH (HOMO SAPIENS IGHV3-23*01 25^26>INS^A (25) (92.8%)-(IGHD)-IGHJ6*01 (92.9%)) (8.8.5) (1-113)-HOMO SAPIENS IGHG4*01 (CH1 (114-211), HINGE S10>P (221) (212-223), CH2 (224-333), CH3 (334-438), CHS (439-440)) (114-440)), (127-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (90.5%)-IGKJ4*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (219-219'':222-222'')-BISDISULFIDE
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN HEPATITIS A VIRUS CELLULAR RECEPTOR 2 (HAVCR-2, T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN-CONTAINING PROTEIN 3, T-CELL MEMBRANE RECEPTOR-3))HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-440) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*01 (92%) (IGHD)-IGHJ6*01 (93%)) (8.8.6) (1-113)-HOMO SAPIENS IGHG4*01 (H S10>P(221)) (114-440)) (127-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-213') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (91%) IGKJ4*01) (6.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (107'-213')), DIMER (219-219'':222-222'')-BISDISULFIDE
TSR022
TSR-022
WBP-296A

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

COBOLIMAB

Synonyms and Mappings

Resources